“It’s great to have a place to visit for reference. I direct people who have been recently diagnosed to the site to learn more about MF, PV and ET and to find the most current factual information.” - Joe Evans, MF since 9/08

Learning About MPNs - PV, ET, PMF

Myeloproliferative neoplasms (MPNs) are a closely related group of hematological malignancies in which the bone marrow cells that produce the body's blood cells develop and function abnormally. The three main myeloproliferative neoplasms are Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF).

The myeloproliferative neoplasms are progressive blood cancers that can strike anyone at any age, and for which there is no known cure. A gene marker, JAK2, was discovered in 2005. It is present in most PV patients and 50% of ET and PMF patients. A second gene marker, Calreticulin or CALR, was discovered in 2013. It is present in 23.5% of people with MF and ET.

Click here to learn more about PV, ET, and PMF, including symptoms, diagnosis, progression, prognosis, possible causes, available treatments and prevalence.

Be sure to also visit our Living With section, and Patient Options.

 

Become a member

Free membership includes MPN Update newsletter, alerts, RFP announcements and more.

Join today

 

 

 

Your donation goes a long way.

Learn more about how you can help support the MPN Research Foundation and the impact your contributions can make.

Donate Now
 
 
 

Connect with Us

MPN Research Foundation wants to hear from you. Connect with us through our social networks or send us an email.

Email Facebook Twitter LinkedIn